The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences
Open accessAbstract
Glucagon‐like peptide‐I(GLP‐I), encoded by the glucagon gene and released from the gut in response to nutrients, is a potent stimulator of glucose‐induced insulin secretion. In human subjects GLP‐I exerts its physiological effect as an incretin. The incretin effect of GLP‐I is preserved in patients with Type II diabetes mellitus (NIDDM), suggesting that GLP‐I receptor agonist can be used therapeutically in this group of patients. In these studies we addressed the question of whether GLP‐I has broader actions in human physiology. To investigate this issue we examined the tissue distribution of GLP‐I receptor using RNAse protection assay in order to avoid the cross‐reactivities with structurally related receptors and to increase the sensitivity of detection. The riboprobe was synthetized from the human pancreatic GLP‐I receptor cDNA and used in hybridization experiments with total RNA isolated from different human tissues. In addition to the pancreas, we found expression of GLP‐I receptor mRNA in lung, brain, kidney, stomach and heart. Peripheral tissues which are the major sites of glucose turnover, such as liver, skeletal muscle and adipose did not express the pancreatic form of the GLP‐I receptor. We also cloned and sequenced GLP‐I receptor cDNA from human brain and heart. The deduced amino acid sequences are the same as the sequence found in the pancreas. These results indicate that GLP‐I might have effects beyond the pancreas, including the cardiovascular and central nervous systems where a receptor with the same ligand binding specificity is found.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1 receptors are also found in the heart and in areas of the central nervous system that govern autonomic control (25, 49).”
From Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans (2008) · cites this paper as [49]
In the citing paper
“GLP-1 acts through a class 2 member of the G-coupled protein C receptor family seven-transmembrane receptor (GLP-1R) (8), which is mainly expressed in pancreatic islets, the brain, and the gastrointestinal (GI) tract (9–12), and less prominently in the kidney and eyes (11–13).”
From The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications (2026) · cites this paper as [9]
In the citing paper
“GLP-1 receptor was found in nerves that innervate hepatocytes [172], but their presence on human liver or hepatocytes is debated as found by some [169,170] but not others [173,174].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [174]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., & Green, M. R. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7035 · Cited by 6,324
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Self-citationHamster preproglucagon contains the sequence of glucagon and two related peptides
Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
ØRSKOV, C., HOLST, J. J., KNUHTSEN, S., BALDISSERA, F. G. A., POULSEN, S. S., & NIELSEN, O. V. (1986) · Endocrinology · doi:10.1210/endo-119-4-1467 · Cited by 482
Research works printed but not linked: 6
- Lopez L.C., 1983, Proc. Natl. Acad. Sci. USA, 5485
- Parker J.C., 1993, Digestion, 54, 357
- Richter G., 1993, Am. J. Physiol., 265, L374
- Mojsov S., 1993, Digestion, 54, 342
- Thorens B., 1992, Proc. Natl. Acad. Sci. USA, 8641
- 10.1210/en.132.1.75 · doi:10.1210/en.132.1.75
Cited by
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“The presence of GLP-1R mRNA in the heart was first demonstrated in rats [380] and humans [381,609].”
BackgroundResultKieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Ban, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S.-S., Drucker, D. J., & Husain, M. (2008) · Circulation · doi:10.1161/circulationaha.107.739938 · Cited by 1,057
Pyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876
Metadata
- Authors
- Wei, Y., & Mojsov, S.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Mojsov, Svetlana
- ORCID
- Mojsov, Svetlana
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 1995-01-30
- Volume
- 358
- Issue
- 3
- Pages
- 219-224
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W1968939832
- Cited by
- 450
- References
- 35
- Citations by year
- 2026: 14 · 2025: 9 · 2024: 16 · 2023: 19 · 2022: 20 · 2021: 18 · 2020: 17 · 2019: 17 · 2018: 11 · 2017: 14 · 2016: 22 · 2015: 23 · 2014: 29 · 2013: 25 · 2012: 30
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Diabetes Action Research and Education Foundation
- University of Chicago
- National Institutes of Health (5r29dk040083-06)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 40083)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- glucagon-like peptide-1, GLP-1 receptor, tissue-specific gene expression, receptor mRNA distribution, brain, heart, pancreas, lung, kidney, stomach, type 2 diabetes, incretins, insulin secretion, receptor cDNA cloning, amino acid conservation
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Amino Acid Sequence, Base Sequence, Brain, Diabetes Mellitus, Type 2, Humans, Molecular Sequence Data, Myocardium, Pancreas, Sequence Homology, Amino Acid, Receptors, Glucagon, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences. https://app.cochat.ai/papers/10.1016/0014-5793(94)01430-9
- The paper
- Wei, Y., & Mojsov, S. (1995). Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Letters. https://doi.org/10.1016/0014-5793(94)01430-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.